Status:
COMPLETED
Impact of Timing of Premedication on Mucosal Visibility During Endoscopy-A Randomized Controlled Trial
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Endoscopy, Digestive System
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
UGI endoscopy(esophagogastroduodenoscopy) is the main diagnostic modality for direct visualization ,real time assessment and interpretation of findings encountered. The evaluation of esophagogastroduo...
Detailed Description
Procedure • Premixed medication (150mg simethicone and 600mg nac with 100ml of water) was given at specified timing Primary objective - comparison of mucosal visibility between 4 groups Secondary obj...
Eligibility Criteria
Inclusion
- Age \>18years
Exclusion
- History of upper gastrointestinal surgery
- Neurological disorders with impaired swallowing
- Active gastrointestinal bleeding,
- Caustic ingestion
- Pregnancy.
- Known history of multiple allergies
- Gastric outlet obstruction
- Esophageal motility disorders
- Contraindication for upper GI endoscopy
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06581783
Start Date
December 1 2024
End Date
April 29 2025
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asian Institute of Gastroenterology /Aig Hospitals
Hyderabad, Telangana, India, 500082